[Alterations in the protein content and dysfunction of high-density lipoproteins from hyperhomocysteinemic mice]
- PMID: 23938051
- DOI: 10.1016/j.arteri.2013.07.001
[Alterations in the protein content and dysfunction of high-density lipoproteins from hyperhomocysteinemic mice]
Abstract
Aim: The aim of this study was to evaluate the proteic changes in high-density lipoproteins (HDL) induced by methionine-induced hyperhomocysteinemia in mice and its relationship with two of their main antiatherogenic properties.
Methods and results: The oral administration of methionine resulted in an elevation (~8 times) in the plasma concentration of homocysteine. Hyperhomocysteinemia was inversely correlated with the plasma concentration of HDL cholesterol and its main protein component of HDL, apolipoprotein (apo) A-I, respectively. The cholesterol efflux in vivo from macrophages to HDL was decreased in hyperhomocysteinemic mice compared with the control mice. However, the reverse cholesterol transport from macrophages to feces remained unchanged. On the other hand, the ability of HDL from hyperhomocysteinemic mice to prevent the oxidative modification of low-density lipoproteins (LDL) was found decreased and associated with a concomitant reduction in the plasma activity of paraoxonase-1 (PON1) and the plasma concentration of apoA-I, and with a relative reduction in the apoA-IV content (~1.5 times) in the hyperhomocysteinemic HDL, respectively.
Conclusion: The decrease in the ability of HDL from hyperhomocysteinemic mice to prevent LDL from oxidation was associated with a decrease in the apoA-I, PON1 and apoA-IV.
Keywords: High-density lipoproteins; Hiperhomocisteinemia; Hyperhomocysteinemia; Lipoproteínas de alta densidad; Proteomics; Proteómica.
Copyright © 2013 Elsevier España, S.L. and SEA. All rights reserved.
Similar articles
-
Methionine-induced hyperhomocysteinemia impairs the antioxidant ability of high-density lipoproteins without reducing in vivo macrophage-specific reverse cholesterol transport.Mol Nutr Food Res. 2013 Oct;57(10):1814-24. doi: 10.1002/mnfr.201300133. Epub 2013 Jun 10. Mol Nutr Food Res. 2013. PMID: 23754667
-
Human apolipoprotein A-II enrichment displaces paraoxonase from HDL and impairs its antioxidant properties: a new mechanism linking HDL protein composition and antiatherogenic potential.Circ Res. 2004 Oct 15;95(8):789-97. doi: 10.1161/01.RES.0000146031.94850.5f. Epub 2004 Sep 23. Circ Res. 2004. PMID: 15388641
-
Cysteinemia, rather than homocysteinemia, is associated with plasma apolipoprotein A-I levels in hyperhomocysteinemia: lipid metabolism in cystathionine beta-synthase deficiency.Atherosclerosis. 2010 Sep;212(1):268-73. doi: 10.1016/j.atherosclerosis.2010.04.028. Epub 2010 May 26. Atherosclerosis. 2010. PMID: 20537649
-
Hepatic lipase- and endothelial lipase-deficiency in mice promotes macrophage-to-feces RCT and HDL antioxidant properties.Biochim Biophys Acta. 2013 Apr;1831(4):691-7. doi: 10.1016/j.bbalip.2013.01.003. Epub 2013 Jan 15. Biochim Biophys Acta. 2013. PMID: 23328279
-
Hyperhomocysteinemia and high-density lipoprotein metabolism in cardiovascular disease.Clin Chem Lab Med. 2007;45(12):1652-9. doi: 10.1515/CCLM.2007.358. Clin Chem Lab Med. 2007. PMID: 18020970 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous